Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

Market Open

Feb 12, 2026 10:15:59 AM EST

124.38USD-9.506%(-13.06)821,160

124.14Bid 125.40Ask 1.26Spread

Pre-market

Feb 11, 2026 9:18:30 AM EST

138.00USD+0.407%(+0.56)0

After-hours

Feb 11, 2026 4:32:30 PM EST

130.22USD-5.250%(-7.21)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

12.39B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

May 6, 2026 (82d)

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

1,084,520

Avg. Vol. 30 Day

1,103,250

Employees

470

Market Cap

12,394,415,318

Shares Out.

99,705,698

On/Off Exchange

63%/37%

6 Month Beta

0.58

1 Year Beta

0.78

2 Year Beta

0.75

3 Year Beta

0.69

52 Week Low

84.23

52 Week High

160.18

SMA50

142.07

SMA200

135.46

1 Week

-9.88%

1 Month

-6.29%

3 Month

-15.35%

6 Month

-3.55%

1 Year

+6.09%

2 Year

-4.69%

5 Year

+8.95%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $124.38, and today's volume is 821,160. NBIX is down -9.506% today. The 30 day average volume is 1,103,250. NBIX market cap is 12.39B with 99,705,698 shares outstanding.